CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 155 filers reported holding CARA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $444,000 | -38.8% | 27,533 | -30.7% | 0.00% | -40.0% |
| Q3 2019 | $726,000 | -22.0% | 39,720 | -8.2% | 0.01% | -28.6% |
| Q2 2019 | $931,000 | +7.6% | 43,247 | -2.0% | 0.01% | 0.0% |
| Q1 2019 | $865,000 | +75.1% | 44,131 | +16.0% | 0.01% | +75.0% |
| Q4 2018 | $494,000 | +88.5% | 38,033 | +247.4% | 0.00% | +100.0% |
| Q3 2018 | $262,000 | +482.2% | 10,948 | +198.0% | 0.00% | – |
| Q2 2018 | $45,000 | 0.0% | 3,674 | 0.0% | 0.00% | – |
| Q1 2018 | $45,000 | +9.8% | 3,674 | +11.1% | 0.00% | – |
| Q4 2017 | $41,000 | -6.8% | 3,308 | +4.7% | 0.00% | – |
| Q3 2017 | $44,000 | +22.2% | 3,158 | +33.4% | 0.00% | – |
| Q2 2017 | $36,000 | -62.5% | 2,368 | -54.5% | 0.00% | -100.0% |
| Q1 2017 | $96,000 | +2300.0% | 5,208 | +1125.4% | 0.00% | – |
| Q4 2016 | $4,000 | +33.3% | 425 | +41.7% | 0.00% | – |
| Q3 2016 | $3,000 | +200.0% | 300 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |